A phase I, open-label study evaluating the safety and pharmacokinetics of trifluridine/tipiracil in patients with advanced solid tumors and varying degrees of renal impairment.
Muhammad Wasif SaifCarlos R BecerraMarwan G FakihWeijing SunLazar PopovicSmitha KrishnamurthiThomas J GeorgeMichelle A RudekDale R ShepardJiri SkopekVladimir SramekBojan ZaricIkuo YamamiyaKarim A BenhadjiKensuke HamadaYaohua HeLee RosenPublished in: Cancer chemotherapy and pharmacology (2021)
NCT02301117, registration date: November 21, 2014.